Featured – News & Media

Technology Plus Science: New Company Model? – PharmaVOICE 2020 Year In Preview

Saama Founder and CEO, Suresh Katta was quoted in PharmaVOICE’s Special 2020 Year In Preview issue in a discussion on what might occur if Apple, Amazon, Google or another big technology company bought a pharma company. “Though the life-sciences industry faces a number of issues, purchasing a pharmaceutical company by tech giants would not solve its current…

Read More

The Year Ahead… – PharmaVOICE 2020 Year In Preview

Founder and CEO, Suresh Katta, was quoted in PharmaVOICE’s Special 2020 Year In Preview issue responding to the question “What if… clinical trials were in-sourced?” “The pharma industry must take control of its own future, and learning to in-source clinical trials would be a monumental step toward self-directing that future,” Mr Katta replies. “Since the…

Read More

The Critical Importance of Real-Time Access to Clinical Study Performance

Saama Technologies Clinical Advisor, Jonathan Zung, PhD, wrote an article for Applied Clinical Trials regarding the importance of clinical trial sponsors having real-time access to shared data. “To paraphrase the 16thcentury English poet John Donne, in today’s global life sciences arena no company is an island. Clinical trial sponsors rely on contract research organizations (CROs), clinical…

Read More

Informa Pharma Intelligence and Saama Technologies Develop New AI/Workflow Tools

Tools Will Improve Citeline Customers’ Trials Design and targeting LONDON – September 30, 2019 – Informa Pharma Intelligence and Saama Technologies today announced a strategic partnership enabling Informa’s Citeline and Saama’s Life Science Analytics Cloud (LSAC) customers to apply world-class AI to both Citeline clinical intelligence expertise and real world evidence to design clinical trials…

Read More

Saama Data Analytics Platform Runs On Machine Learning

Senior VP of Clinical Innovations, Amit Gulwadi, was featured in an article from Clinical Research News on the different ways that the LSAC makes use of machine learning. “In the world of clinical development, information is stored in a multitude of places, from clinical trial management systems and electronic data capture systems to third-party labs…

Read More

Saama Acquires Comprehend to Form Preeminent Clinical Analytics Platform Company

Transaction Creates Expanded Portfolio of Cloud-Based Capabilities to Advance Clinical Development CAMPBELL, CA and REDWOOD CITY, CA – (August 13, 2019) – Saama Technologies, Inc. (“Saama”) announced today that it has signed a definitive agreement to acquire Comprehend Systems, Inc. (“Comprehend”). This agreement combines Saama and Comprehend’s respective industry positions as leading clinical data analytics…

Read More

Saama Challenges Analytics Industry to Guarantee Data Platforms to Help Accelerate Drug Development

Company Leads Call-to-Action by Issuing Saama Product Guarantee on Clinical Trials Day CAMPBELL, CA – (May 20, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, issued a call-to-action on Clinical Trials Day urging the analytics industry to commit to timely deployment of solutions for biopharmaceutical companies and the elimination of launch…

Read More

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

CAMPBELL, CA – (March 25, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and…

Read More

Related Posts